Physician profile
John Nicholas Bertini
NPI 1225267982
$1,540.94
in general payments reported to CMS, 2019-2025
14 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $65.48 · 2023: $259 · 2024: $711 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,475.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $476.48 | 2022-2025 | Ubrelvy, Vraylar, Qulipta |
| Novo Nordisk INC | $247.69 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $181.24 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbott Laboratories | $170.31 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Pfizer INC. | $75.67 | 2024-2025 | |
| Exact Sciences Corporation | $62.41 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $58.29 | 2024 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $57.96 | 2023-2024 | Farxiga, Airsupra |
| Phathom Pharmaceuticals, INC. | $52.23 | 2024-2025 | Voquezna |
| Inspire Medical Systems, INC. | $47.22 | 2025 | Inspire |
| Sumitomo Pharma America, INC. | $36.85 | 2024-2025 | Gemtesa |
| Amgen INC. | $34.78 | 2024-2025 | Repatha, Otezla, Repatha |
| Daiichi Sankyo INC. | $25.00 | 2024 | Injectafer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.81 | 2024 | Xifaxan, Trulance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bertini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.